Favour O. Igwezeke

PharmD candidate · Machine learning × biology

Favour O. Igwezeke

I am a final-year PharmD student at the University of Nigeria, Nsukka, working at the intersection of machine learning and biology.

My research focuses on mechanism-grounded representation learning: building models that preserve biologically meaningful structure rather than depend on context-specific shortcuts, and using distribution shift and perturbations to test what those representations actually encode. I also study uncertainty-aware reasoning over structured biomedical knowledge.

Currently, I work with Collins A. Onyeto on computational toxicology, including single-cell models of toxicity risk, and Charles O. Nnadi on computational drug discovery. Beyond UNN, I actively collaborate with the CaresAI Research Group, led by Mary Adewunmi, on knowledge discovery and reasoning in clinical AI, and with the SPARK Academy on prior-informed representation learning for medical imaging under the supervision of Udunna Anazodo. Previously, I completed research internships in cancer genomics at the Genomac Institute and NGS bioinformatics at HackBio.

Research focus

I want to understand how biological representations can remain meaningful under distribution shift and how they can be reused to reason about unseen biological contexts.

More specifically, my work asks why apparently similar biological states respond differently when context or intervention changes, what underlying structure produces that context-dependence, and how models can distinguish stable biological relationships from context-specific correlations.

I pursue these questions primarily through single-cell genomics, perturbation modelling, trajectory inference, and drug-response prediction, with related work in uncertainty-aware biomedical AI.

Research

Selected publications

My name is bolded. Abstracts and BibTeX expand in place.

MORPHA framework deriving stage-conditioned morphology statistics, applying a consistency loss, and evaluating cross-acquisition transfer

MORPHA: Morphology-Constrained Training and the Limits of Cross-Acquisition Transfer in Low-Resource Malaria Microscopy

F. O. Igwezeke, C. H. Ugwuishiwu, J. U. Emesiani, S. I. Agada, E. L. Anozie, M. O. Kama, A. C. Emegoakor

arXiv:2609.05990 · Accepted at MIRASOL @ MICCAI 2026 · Springer LNCS proceedings forthcoming

We introduce a morphology-grounded consistency constraint that improves thin-to-thick-smear classification transfer and calibration, while mapping where acquisition shift defeats detection and pseudo-labelling.

arXiv PDF OpenReview Workshop
Bib

BibTeX

@misc{igwezeke2026morpha,
  title         = {{MORPHA}: Morphology-Constrained Training and the Limits of Cross-Acquisition Transfer in Low-Resource Malaria Microscopy},
  author        = {Igwezeke, Favour Okechukwu and Ugwuishiwu, Chikodili Helen and Emesiani, Joseph Uzochukwu and Agada, Samuel Ifebuche and Anozie, Ekenechukwu Lilian and Kama, Mary Ofuru and Emegoakor, Adaobi Chiazor},
  year          = {2026},
  eprint        = {2609.05990},
  archivePrefix = {arXiv},
  primaryClass  = {cs.CV},
  doi           = {10.48550/arXiv.2609.05990},
  note          = {Accepted for poster presentation at MIRASOL 2026, a MICCAI 2026 workshop},
  url           = {https://arxiv.org/abs/2609.05990}
}
Abstract

Abstract

MORPHA encodes stage-conditioned morphology statistics from BBBC041 as a soft training constraint and evaluates the same idea across binary classification, detection, and stage-aware malaria microscopy under transfer from thin-smear sources to Lacuna field images from Uganda.

For binary classification, the constraint improves Lacuna F1 from 0.5783 to 0.6992 and reduces in-distribution calibration error with negligible source-domain cost. Content-free controls show that measured morphology contributes to the gain, although generic confidence regularisers transfer better. Detection and pseudo-labelling fail across the acquisition boundary, showing that thin-smear benchmarks cannot stand in for thick-smear deployment.

Workflow and biomarker results for lncRNA monitoring of hepatocellular carcinoma immunotherapy response

Exploring lncRNAs as Biomarkers for Monitoring Hepatocellular Carcinoma Immunotherapy Response

A. J. Ogunleye*, Y. El-Tony*, A. A. Adegite*, F. O. Igwezeke†, S. M. Mahdi†, M. A. Mohamed†, T. Orimolade†, O. Osatoyinbo†

Research Square preprint · Manuscript under review at Gene · 2026

We profile treatment-responsive lncRNA programs in hepatocellular carcinoma and derive a 12-lncRNA panel for tracking immune-checkpoint therapy progression.

Preprint PDF DOI
Bib

BibTeX

@article{ogunleye2026exploring,
  title   = {Exploring lncRNAs as Biomarkers for Monitoring Hepatocellular Carcinoma Immunotherapy Response},
  author  = {Ogunleye, Adewale J. and El-Tony, Yossra and Adegite, Adejuwon A. and Igwezeke, Favour O. and Mahdi, S. M. and Mohamed, M. A. and Orimolade, Tinuoluwanimi and Osatoyinbo, Opemidimeji},
  journal = {Research Square},
  year    = {2026},
  note    = {Preprint; manuscript under review at Gene},
  doi     = {10.21203/rs.3.rs-10483008/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10483008/v1}
}
Abstract

Abstract

Hepatocellular carcinoma is one of the deadliest malignancies globally, and overall immunotherapy response rates remain poor. We systematically investigated long non-coding RNAs in a cohort of HCC patients treated with nivolumab and ipilimumab followed by surgical resection.

Differentially expressed lncRNAs were identified from RNA-seq data for 69 tumor samples and interpreted through a guilt-by-association framework. The analysis identified stage-specific and treatment-responsive lncRNAs and produced a 12-lncRNA panel that tracked immunotherapy progression.

Framework for predicting independent tumor, node, and metastasis stages from TCGA pathology reports

CaresAI at SMM4H-HeaRD 2026: Predicting TNM Staging

J. I. Abubakar, J. Jarme, F. Igwezeke, M. Adewunmi

SMM4H-HeaRD @ ACL 2026 · Association for Computational Linguistics · pp. 206–210

We compare TF–IDF, biomedical BERT encoders, and neural classifiers for TNM staging from pathology reports, then examine the generalization drop on harder, less explicit cases.

Paper arXiv PDF Code
Bib

BibTeX

@inproceedings{abubakar-etal-2026-caresai,
  title     = {{C}ares{AI} at {SMM}4{H}-{H}ea{RD} 2026: Predicting {TNM} Staging},
  author    = {Abubakar, Joseph Itopa and Jarme, Jorge and Igwezeke, Favour and Adewunmi, Mary},
  booktitle = {Proceedings of the 11th Social Media Mining for Health Research and Applications (SMM4H-HeaRD 2026) Workshop and Shared Tasks},
  month     = jul,
  year      = {2026},
  address   = {San Diego, United States},
  publisher = {Association for Computational Linguistics},
  pages     = {206--210},
  doi       = {10.18653/v1/2026.smm4h-1.32},
  url       = {https://aclanthology.org/2026.smm4h-1.32/}
}
Abstract

Abstract

The Tumor, Node, and Metastasis (TNM) staging system is critical to cancer treatment. This study predicts TNM stage labels independently from TCGA pathology reports and frames the problem as three multi-label classification tasks.

We explore classical and deep-learning approaches using TF–IDF features and representations from ClinicalBERT, BioBERT, and PubMedBERT with Logistic Regression, LightGBM, feed-forward networks, and wide residual networks. Although the resulting pipeline provides strong, reproducible baselines, performance falls on the harder test set, highlighting class imbalance, lengthy-document processing, and generalization as priorities for further work.

Comparison of biomedical text encoders for dosage-error prediction

CaresAI at CT-DEB’26: Detecting Dosing Errors in Clinical Trials Using Domain-Specific Transformer Embeddings and Classification Models

L. Hamnett, F. Igwezeke, J. I. Abubakar, M. A. Adewunmi

Third Workshop on Patient-Oriented Language Processing (CL4Health) @ LREC 2026 · pp. 344–361

We combine domain-specific transformer embeddings with structured trial metadata to flag elevated dosing-error risk; BioBERT outperforms ClinicalBERT, while stacking encoders adds little.

Proceedings arXiv PDF Code
Bib

BibTeX

@inproceedings{hamnett-etal-2026-caresai,
  title     = {{C}ares{AI} at {CT}-{DEB}'26: Detecting Dosing Errors in Clinical Trials Using Domain-Specific Transformer Embeddings and Classification Models},
  author    = {Hamnett, Leon and Igwezeke, Favour and Abubakar, Joseph Itopa and Adewunmi, Mary Adetutu},
  booktitle = {Proceedings of the Third Workshop on Patient-Oriented Language Processing (CL4Health)},
  year      = {2026},
  address   = {Palma, Mallorca, Spain},
  publisher = {European Language Resources Association},
  pages     = {344--361},
  doi       = {10.63317/4nqo2dmobwrq},
  url       = {https://lrec.elra.info/lrec2026-ws-cl4health-30}
}
Abstract

Abstract

Medication errors, particularly dosing errors in clinical trials, can lead to patient harm, adverse drug events, and worse outcomes. This study evaluates transformer-based representations of trial information for detecting elevated dosing-error risk.

Clinical-trial text was encoded with ClinicalBERT, PubMedBERT, BioBERT, and MedCPT and integrated with categorical features. BioBERT produced the strongest logistic-regression result, while combining multiple embeddings did not improve performance, suggesting that domain alignment mattered more than representational stacking.

TransQSAR-pf feature importance grouped by biological function

TransQSAR-pf: A Bio-Informed QSAR Framework Using Plasmodium falciparum Stress Signatures for Enhanced Antiplasmodial Activity Prediction

F. O. Igwezeke, C. O. Nnadi

Engineering Proceedings 124(1), 37 · 2026

We integrate P. falciparum stress-response transcriptomics with molecular descriptors, improving QSAR accuracy while surfacing conserved, poorly characterized genes as mechanistic hypotheses.

Paper PDF DOI
Bib

BibTeX

@article{igwezeke2026transqsar,
  title   = {{TransQSAR-pf}: A Bio-Informed {QSAR} Framework Using {Plasmodium falciparum} Stress Signatures for Enhanced Antiplasmodial Activity Prediction},
  author  = {Igwezeke, Favour O. and Nnadi, Charles O.},
  journal = {Engineering Proceedings},
  year    = {2026},
  volume  = {124},
  number  = {1},
  pages   = {37},
  doi     = {10.3390/engproc2026124037},
  url     = {https://doi.org/10.3390/engproc2026124037}
}
Abstract

Abstract

Traditional QSAR modeling relies on molecular descriptors while neglecting the biological state of the target organism. TransQSAR-pf integrates Plasmodium falciparum transcriptomic stress signatures with molecular descriptors to create a biologically informed activity-prediction model.

Applied to 125 triazolopyrimidine derivatives, the framework distilled 764 transcriptomic features into 13 predictors and improved on the QSAR-only baseline. Most feature importance came from conserved unknown-function genes, making the framework useful for both prediction and mechanistic hypothesis generation.

Research communication

Talks, presentations & posters

Oral presentations

Title slide for the absuite short talk at BioC2026

absuite: An R/Bioconductor Package for Antibody Repertoire Profiling and Clonotype Analysis

Short talk · BioC2026 (Bioconductor Conference) · Seattle, WA · Aug. 2026

An introduction to absuite and its workflow for reproducible antibody repertoire profiling, clonotype analysis, and visual exploration in R.

Title slide for the absuite oral presentation at ISMB 2026

absuite: A Package in R for Antibody Repertoire Profiling and Clonotype Analysis

Oral presentation · ISMB 2026 (34th Conference on Intelligent Systems for Molecular Biology) · Georgetown · Jul. 2026

An oral presentation of absuite, including its design for repertoire quality control, diversity profiling, and clonotype analysis in reproducible R workflows.

Posters

MORPHA poster presented at the MIRASOL Workshop at MICCAI 2026

MORPHA: Morphology-Constrained Training and the Limits of Cross-Acquisition Transfer in Low-Resource Malaria Microscopy

Poster · MIRASOL Workshop @ MICCAI 2026 · Strasbourg, France · Sep. 2026

Morphology-constrained training for low-resource malaria microscopy, testing when measured parasite morphology improves cross-acquisition transfer and where it fails.

CT-DEB'26 figure comparing pretrained biomedical text encoders

CaresAI at CT-DEB’26

Virtual poster presentation · CL4Health @ LREC 2026

Domain-specific biomedical encoders and structured trial metadata for detecting elevated dosing-error risk in clinical-trial protocols.

Meningioma genomics poster presented at the CoGSAYR Africa Summit 2026

Comparative Analysis of Tumor Mutational Burden and Copy Number Alterations in WHO-Graded Meningiomas

Poster · Consortium of Genomics Students and Young Researchers in Africa (CoGSAYR Africa), 2026 Africa Summit · Lagos · Jan. 2026

A multi-omics comparison of tumor mutational burden and copy number alteration burden across WHO meningioma grades, with genomic features evaluated for grade prediction.

TransQSAR-pf poster presented at ASEC 2025

TransQSAR-pf: A Bio-Informed QSAR Framework Using Plasmodium falciparum Stress Signatures for Enhanced Antiplasmodial Activity Prediction

Poster · 6th International Electronic Conference on Applied Sciences (ASEC 2025) · p. 24 · Dec. 2025

A biology-informed QSAR framework integrating P. falciparum transcriptomic stress signatures with molecular descriptors to improve activity prediction and surface candidate mechanisms.

Meningioma genomics poster presented at the ISPOR-HEOR UNN Health Conference

Comparative Analysis of Tumor Mutational Burden and Copy Number Alterations in WHO-Graded Meningiomas

Poster · ISPOR-HEOR UNN Health Conference · Nsukka, Nigeria · Nov. 2025

A conference presentation examining tumor mutational burden and copy number alterations as quantitative genomic markers for meningioma grade and risk stratification.